09 Mar Collaboration agreement between GENESIS Biomed SL and REGIC
This post is also available in: ES (Spanish)
REGIC, as an entity committed to good practices, sharing experiences and creating a space for interaction linked to the management of research and innovation in health, is concerned with helping its associates to have access to information and training on the sector.
Our associates are managing entities of clinical and biomedical research, but at REGIC, we know that research needs many agents involved, and it is our intention to bring them closer and involve them through other modes of relationship.
We have signed collaboration agreements with the platforms and public bodies, and for the rest of the agents, we present a sponsorship policy that allows them to channel their relationship with REGIC and all its associates.
In this way, we are pleased to inform that, on March 1, 2021, REGIC has signed an agreement with GENESIS Biomed, as a scientific-technological sponsor.
Josep Lluís Falcó, CEO and co-founder of GENESIS Biomed, values very positively this collaboration agreement. “To advance in research, it is essential to share experiences and create spaces for collaboration. We have learned in all these years that sharing knowledge and information adds value to the system. That is why we believe that collaborating with REGIC will help us to provide our clients with an added value of great importance”.
GENESIS Biomed is a consulting firm operating in the biomedical sector specialized in providing services to newly formed companies, both spin-offs and start-ups, mostly from universities, research centers, hospitals and technology centers. With headquarters in Barcelona and offices in Madrid, GENESIS Biomed is a leading player at the national level and with a clear international vocation, firmly betting on entrepreneurship and business development in the biomedical sector. Created in May 2017, it has already raised more than 60 million euros and has worked on 130 innovation projects of different types.